Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

Holz F.G., Amoaku W., Donate J., Guymer R.H., Kelnner U., Schlingenmann R.O,. Weichselberger A., Staurenghi G., on behalf of the SUSTAIN Study Group

Ophthalmology 2011; 118:663-671

2011